Global Autoimmune Disease Diagnostics Market

Global Autoimmune Disease Diagnostics Market: Insights

Autoimmune disease is a medical condition where the immune system of the human body fallaciously attacks certain healthy body parts. In usual cases, the immune system protects the body from bad bacteria and harmful external microorganisms by using the fighter cells in the body. However, in conditions like autoimmune disease, the immune system with its fighter cells attack the healthy part or organs of the body with its proteins like autoantibodies, which basically attack the healthy cells in these parts. While some autoimmune diseases like systemic lupus erythematous (SLE) attack the entire body, others, like type 1 diabetes, attack a single organ like the pancreas. These increasing cases and the percentage of the population with autoimmune disease accelerate growth within the autoimmune disease diagnostics market.

Studies and surveys have shown that a country like the United States reports approximately more than 23.5 million people with autoimmune diseases every year. These surveys have also proved the fact that autoimmune diseases are more typical in females than in males. These autoimmune diseases are also one of the primary causes of death in countries like these. This increasing number of autoimmune disease has severe implications if left undiagnosed or untreated. Thus, countries like the United States tremendously contribute to the increasing growth of autoimmune disease diagnostics in the global market. Studies have shown that there are approximately 80 types of autoimmune diseases, out of which few attack one organ at a time. Studies have also been unsuccessful in figuring the root cause behind autoimmune diseases, although some have vaguely stated that these diseases can be related to genetics and family history. Besides genetics of family inheritance, some changing environmental factors can have an impact on body working or exposure to various bacteria that trigger autoimmune diseases. Also, there are high chances or risks of a person developing another autoimmune disease after getting affected or diagnosed by one in the past. This increasing awareness about the risks and consequences of autoimmune diseases is making people opt for autoimmune disease diagnostics as a part of regular check-ups to be assured and take necessary precautions, thus boosting the demand and growth in the autoimmune disease diagnostics market.

The symptoms attributed by a person with autoimmune disease are pretty similar and can overlap with the systems of other diseases, making it difficult to diagnose. However, the technological advancements in the diagnostic processes, along with automated equipment and techniques, have made it easy for professionals to diagnose these autoimmune diseases accurately. Medical science has proved that there is no specific management for autoimmune diseases. However, early diagnosis can enable doctors to recommend treatments that can slow down the progression and impact of autoimmune disease and can be beneficial for a better quality of life. Also, despite having no concrete cure, doctors do prescribe drugs and medications for treating autoimmune diseases, and easy accessibility and availability of these antibiotics and medications have also been propelling growth in the autoimmune disease diagnostics market.

Today, many governmental bodies have also been encouraging the respective medical and healthcare sectors to undertake sufficient research and development in order to handle the increasing autoimmune diseases more efficiently. This increased ratio of research and development is also enabling professionals to adopt techniques that deliver a quick and accurate diagnosis, which can be relied on and subsequently be treated. In recent years, the medical sector has also witnessed increased investments through various authorities, thus boosting growth in the autoimmune disease diagnostics market.

Global Autoimmune Disease Diagnostics Market: By Type

Based on the type, the autoimmune disease diagnostics market is categorized as systemic autoimmune disease diagnostics and localized autoimmune disease diagnostics. Amongst these, localized autoimmune disease diagnostics holds the largest share, thus dominating the market over systemic autoimmune disease diagnostics. The rate of autoimmune diseases affecting a single organ or body part at a time is comparatively more than the autoimmune diseases affecting multiple organs or body parts at a time. Thus, localized autoimmune disease diagnostics are utilized significantly within the medical sector by professionals compared to systemic autoimmune disease diagnostics. The increasing rate of emerging organ-specific specialists also subsequently increases the demand for localized autoimmune disease diagnostics. Type 1 diabetes affecting a single pancreatic organ is prevalent among various countries in the majority, thus requiring localized autoimmune disease diagnostics. Also, Hashimoto's Thyroiditis is commonly reported in more significant numbers in various countries.

However, followed by localized autoimmune disease diagnostics, systemic autoimmune disease diagnostics is also expected to witness fast growth within the market throughout the forecast period. Systemic autoimmune diseases usually are seen within multiple organs or body parts at the same time. These are majorly classified or segmented into vasculitis disorders and rheumatological disease. The increasing number of cases and severity of autoimmune diseases in various countries are demanding diagnostics like systemic autoimmune disease diagnostics, which are more advanced and can be used on various organs simultaneously to get more efficient and effective diagnostic results.

Global Autoimmune Disease Diagnostics Market: By Region

Based on regional segmentation, North America holds the largest share in the market. Organizations like the National Institute of Health (NIH) have been working in the North American region to develop research on various medical fields and areas. Organizations like these have contributed tremendously in identifying 80 types of autoimmune diseases. Also, countries like the United States report having autoimmune disease as one of the top ten reasons behind increasing death rates in the country.

However, Asia Pacific is expected to witness the fastest growth within the market throughout the forecast period. Countries like China and India have an enormous population, thus having significant autoimmune diseases being reported every year. With their improving medical sector, these countries are gaining more and more awareness about these diseases. They are encouraging their respective healthcare sectors to undertake research and development to manage the increased ratios of these, thus accelerating growth in the diagnostics market. India has also witnessed an increase in the number of professionals or organ-specific specialists and massive investments into the medical sector, thus increasing the demand for more accurate diagnostics. Improving technology and advancements in technical processes also enable the professionals to effectively deal with the severity of the disease, thus accelerating growth within the autoimmune disease diagnostics market of the APAC region.

Global Autoimmune Disease Diagnostics Market Share & Competitor Analysis

Abbott Laboratories, AESKU.Diagnostics GmbH & Co. KG, Crescendo Bioscience, Inc., Bio-Rad Laboratories, Inc., bioMerieux SA, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Beckman Coulter, Inc., SQI Diagnostics, Quest Diagnostics, EUROIMMUN AG, INOVA Diagnostics, Inc., and Hemagen Diagnostics, Inc., are few prominent competitors in the market.

Please note: This is not an exhaustive list of companies profiled in the report.